Concepedia

Marie-Elisabeth Goebeler

MG

6

Publications

953

Citations

6

H-Index

2011

Active since

Affiliations

University Hospital Schleswig-Holstein(Current)

University of Lübeck

Comprehensive Cancer Center Mainfranken

University Hospital Ulm

Goethe University Frankfurt

Marie-Elisabeth Goebeler is an author at University Hospital Schleswig-Holstein specializing in cancer research, tumor immunity, and oncology.

Top concepts

Publications per year

2011–2016

6

Publications

6

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier et al. · Blood · 2012 · 466 citations · Full text

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

Andreas Viardot, Marie-Elisabeth Goebeler, Svenja Neumann et al. · Blood · 2016 · 358 citations · Full text

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate and Prolongs Overall Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

Max S. Topp, Nicola Goekbuget, Gerhard Zugmaier et al. · Blood · 2012 · 43 citations

A phase I study of  EpCAM/CD3-bispecific antibody (MT110) in patients with advanced solid tumors.

Walter Fiedler, M. Wolf, Maxim Kebenko et al. · Journal of Clinical Oncology · 2012 · 36 citations

, , +17

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Max S. Topp, Nicola Goekbuget, Gerhard Zugmaier et al. · Blood · 2011 · 32 citations

Rows per page

1–5 of 6